Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 73 Pages
Report ld: 4164702
Request Sample
Customized Report
The global Beta-Eudesmol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
The North America Beta-Eudesmol market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Beta-Eudesmol include Santa Cruz Biotechnology (SCBT), Merck KGaA (Sigma-Aldrich), AdooQ, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Beta-Eudesmol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Eudesmol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Beta-Eudesmol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Beta-Eudesmol manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Beta-Eudesmol revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Beta-Eudesmol Product Scope
1.2 Beta-Eudesmol by Type
1.2.1 Global Beta-Eudesmol Sales by Type (2020 & 2024 & 2031)
1.2.2 Natural Type
1.2.3 Synthetic Type
1.3 Beta-Eudesmol by Application
1.3.1 Global Beta-Eudesmol Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Essence
1.3.3 Sanitary Products
1.3.4 Industrial Products
1.3.5 Others
1.4 Global Beta-Eudesmol Market Estimates and Forecasts (2020-2031)
1.4.1 Global Beta-Eudesmol Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Beta-Eudesmol Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Beta-Eudesmol Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Beta-Eudesmol Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Beta-Eudesmol Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Beta-Eudesmol Sales Market Share by Region (2020-2025)
2.2.2 Global Beta-Eudesmol Revenue Market Share by Region (2020-2025)
2.3 Global Beta-Eudesmol Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Beta-Eudesmol Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Beta-Eudesmol Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Beta-Eudesmol Market Size and Prospective (2020-2031)
2.4.2 Europe Beta-Eudesmol Market Size and Prospective (2020-2031)
2.4.3 China Beta-Eudesmol Market Size and Prospective (2020-2031)
2.4.4 Japan Beta-Eudesmol Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Beta-Eudesmol Historic Market Review by Type (2020-2025)
3.1.1 Global Beta-Eudesmol Sales by Type (2020-2025)
3.1.2 Global Beta-Eudesmol Revenue by Type (2020-2025)
3.1.3 Global Beta-Eudesmol Price by Type (2020-2025)
3.2 Global Beta-Eudesmol Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Beta-Eudesmol Sales Forecast by Type (2026-2031)
3.2.2 Global Beta-Eudesmol Revenue Forecast by Type (2026-2031)
3.2.3 Global Beta-Eudesmol Price Forecast by Type (2026-2031)
3.3 Different Types Beta-Eudesmol Representative Players
4 Global Market Size by Application
4.1 Global Beta-Eudesmol Historic Market Review by Application (2020-2025)
4.1.1 Global Beta-Eudesmol Sales by Application (2020-2025)
4.1.2 Global Beta-Eudesmol Revenue by Application (2020-2025)
4.1.3 Global Beta-Eudesmol Price by Application (2020-2025)
4.2 Global Beta-Eudesmol Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Beta-Eudesmol Sales Forecast by Application (2026-2031)
4.2.2 Global Beta-Eudesmol Revenue Forecast by Application (2026-2031)
4.2.3 Global Beta-Eudesmol Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Beta-Eudesmol Application
5 Competition Landscape by Players
5.1 Global Beta-Eudesmol Sales by Players (2020-2025)
5.2 Global Top Beta-Eudesmol Players by Revenue (2020-2025)
5.3 Global Beta-Eudesmol Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Eudesmol as of 2024)
5.4 Global Beta-Eudesmol Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Beta-Eudesmol, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Beta-Eudesmol, Product Type & Application
5.7 Global Key Manufacturers of Beta-Eudesmol, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Beta-Eudesmol Sales by Company
6.1.1.1 North America Beta-Eudesmol Sales by Company (2020-2025)
6.1.1.2 North America Beta-Eudesmol Revenue by Company (2020-2025)
6.1.2 North America Beta-Eudesmol Sales Breakdown by Type (2020-2025)
6.1.3 North America Beta-Eudesmol Sales Breakdown by Application (2020-2025)
6.1.4 North America Beta-Eudesmol Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Beta-Eudesmol Sales by Company
6.2.1.1 Europe Beta-Eudesmol Sales by Company (2020-2025)
6.2.1.2 Europe Beta-Eudesmol Revenue by Company (2020-2025)
6.2.2 Europe Beta-Eudesmol Sales Breakdown by Type (2020-2025)
6.2.3 Europe Beta-Eudesmol Sales Breakdown by Application (2020-2025)
6.2.4 Europe Beta-Eudesmol Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Beta-Eudesmol Sales by Company
6.3.1.1 China Beta-Eudesmol Sales by Company (2020-2025)
6.3.1.2 China Beta-Eudesmol Revenue by Company (2020-2025)
6.3.2 China Beta-Eudesmol Sales Breakdown by Type (2020-2025)
6.3.3 China Beta-Eudesmol Sales Breakdown by Application (2020-2025)
6.3.4 China Beta-Eudesmol Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Beta-Eudesmol Sales by Company
6.4.1.1 Japan Beta-Eudesmol Sales by Company (2020-2025)
6.4.1.2 Japan Beta-Eudesmol Revenue by Company (2020-2025)
6.4.2 Japan Beta-Eudesmol Sales Breakdown by Type (2020-2025)
6.4.3 Japan Beta-Eudesmol Sales Breakdown by Application (2020-2025)
6.4.4 Japan Beta-Eudesmol Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Santa Cruz Biotechnology (SCBT)
7.1.1 Santa Cruz Biotechnology (SCBT) Company Information
7.1.2 Santa Cruz Biotechnology (SCBT) Business Overview
7.1.3 Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Santa Cruz Biotechnology (SCBT) Beta-Eudesmol Products Offered
7.1.5 Santa Cruz Biotechnology (SCBT) Recent Development
7.2 Merck KGaA (Sigma-Aldrich)
7.2.1 Merck KGaA (Sigma-Aldrich) Company Information
7.2.2 Merck KGaA (Sigma-Aldrich) Business Overview
7.2.3 Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck KGaA (Sigma-Aldrich) Beta-Eudesmol Products Offered
7.2.5 Merck KGaA (Sigma-Aldrich) Recent Development
7.3 AdooQ
7.3.1 AdooQ Company Information
7.3.2 AdooQ Business Overview
7.3.3 AdooQ Beta-Eudesmol Sales, Revenue and Gross Margin (2020-2025)
7.3.4 AdooQ Beta-Eudesmol Products Offered
7.3.5 AdooQ Recent Development
8 Beta-Eudesmol Manufacturing Cost Analysis
8.1 Beta-Eudesmol Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Beta-Eudesmol
8.4 Beta-Eudesmol Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Beta-Eudesmol Distributors List
9.3 Beta-Eudesmol Customers
10 Beta-Eudesmol Market Dynamics
10.1 Beta-Eudesmol Industry Trends
10.2 Beta-Eudesmol Market Drivers
10.3 Beta-Eudesmol Market Challenges
10.4 Beta-Eudesmol Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 124
USD 3950.00
(Single User License)
The global Beta-Eudesmol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 116
USD 2900.00
(Single User License)
The global Beta-Eudesmol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 114
USD 4900.00
(Single User License)
The global market for Beta-Eudesmol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 81
USD 2900.00
(Single User License)
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 85
USD 3950.00
(Single User License)
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published Date: 2024-04-07
Pages: 74
USD 4900.00
(Single User License)
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published Date: 2024-02-05
Pages: 84
USD 2900.00
(Single User License)
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 124
The global Beta-Eudesmol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 116
The global Beta-Eudesmol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 114
The global market for Beta-Eudesmol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 81
The global market for Beta-Eudesmol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 85
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published: 2024-04-07
Pages: 74
Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
Published: 2024-02-05
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now